Cite
HARVARD Citation
Langley, R. et al. (n.d.). THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials. Annals of the rheumatic diseases. p. 253. [Online].